Omalizumab for management of hypersensitivity reactions to anticancer drugs

被引：0
作者：
Grover, Piyush [1 ,2 ,3 ]
Krummenacher, Matthew [1 ]
Loy, Timothy [1 ]
Nowak, Anna K. [2 ]
Lucas, Michaela [1 ,2 ,4 ,5 ]
机构：
[1] Sir Charles Gairdner Hosp, Dept Immunol, Perth, WA, Australia
[2] Univ Western Australia, Med Sch, Perth, WA, Australia
[3] Fiona Stanley Hosp, Dept Med Oncol, Perth, WA, Australia
[4] Perth Childrens Hosp, Dept Immunol, Perth, WA, Australia
[5] PathWest, Perth, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2024年 / 54卷 / 08期
关键词：
allergy; cancer drugs; omalizumab; desensitisation; DESENSITIZATION; IGE; ASTHMA;
D O I：
10.1111/imj.16464
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hypersensitivity reactions to anticancer drugs include treatment-limiting toxicity. Standard drug desensitisation offers temporary tolerance and hence requires repetition. We used omalizumab, an anti-immunoglobulin E antibody, to overcome immediate and delayed hypersensitivity reactions to various anticancer drugs. Seven of the eight patients in the current study successfully resumed the desired anticancer drug regimen without standard desensitisation. No safety issues from omalizumab were observed.
引用
收藏
页码：1396 / 1400
页数：5
相关论文
共 21 条
  • [11] Li JR, 2020, J CLIN ONCOL, V38
  • [12] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
    Maurer, Marcus
    Rosen, Karin
    Hsieh, Hsin-Ju
    Saini, Sarbjit
    Grattan, Clive
    Gimenez-Arnau, Ana
    Agarwal, Sunil
    Doyle, Ramona
    Canvin, Janice
    Kaplan, Allen
    Casale, Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) : 924 - 935
  • [13] Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin
    Narui, Chikage
    Tanabe, Hiroshi
    Shapiro, Jason S.
    Nagayoshi, Yoko
    Maruta, Takenori
    Inoue, Momoko
    Hirata, Yukihiro
    Komazaki, Hiromi
    Takano, Hirokuni
    Niimi, Shigeki
    Isonishi, Seiji
    Okamoto, Aikou
    [J]. IN VIVO, 2019, 33 (06): : 2045 - 2050
  • [14] Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels
    Ojaimi, Samar
    Harnett, Paul R.
    Fulcher, David A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (01) : 105 - 106
  • [15] Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab
    Prieto-Garcia, A.
    Noguerado, B.
    Rojas, P.
    Torrado, I
    Rodriguez-Fernandez, A.
    Tornero, P.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (01) : 53 - 55
  • [16] Cancer statistics, 2023
    Siegel, Rebecca L.
    Miller, Kimberly D.
    Wagle, Nikita Sandeep
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (01) : 17 - 48
  • [17] Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
    Sloane, David
    Govindarajulu, Usha
    Harrow-Mortelliti, Jacob
    Barry, William
    Hsu, Florence Ida
    Hong, David
    Laidlaw, Tanya
    Palis, Ross
    Legere, Henry
    Bunyavanich, Supinda
    Breslow, Rebecca
    Wesemann, Duane
    Barrett, Nora
    Brennan, Patrick
    Chong, Hey Jin
    Liu, Anne
    Fernandez, James
    Fanning, Laura
    Kyin, Timothy
    Cahill, Katherine
    Bankova, Lora
    Lynch, Ashly
    Berlin, Suzanne
    Campos, Susana
    Fuchs, Charles
    Mayer, Robert
    Matulonis, Ursula
    Castells, Mariana
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (03) : 497 - 504
  • [18] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Stupp, R
    Mason, WP
    van den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, MJB
    Belanger, K
    Brandes, AA
    Marosi, C
    Bogdahn, U
    Curschmann, J
    Janzer, RC
    Ludwin, SK
    Gorlia, T
    Allgeier, A
    Lacombe, D
    Cairncross, JG
    Eisenhauer, E
    Mirimanoff, RO
    Van Den Weyngaert, D
    Kaendler, S
    Krauseneck, P
    Vinolas, N
    Villa, S
    Wurm, RE
    Maillot, MHB
    Spagnolli, F
    Kantor, G
    Malhaire, JP
    Renard, L
    De Witte, O
    Scandolaro, L
    Vecht, CJ
    Maingon, P
    Lutterbach, J
    Kobierska, A
    Bolla, M
    Souchon, R
    Mitine, C
    Tzuk-Shina, T
    Kuten, A
    Haferkamp, G
    de Greve, J
    Priou, F
    Menten, J
    Rutten, I
    Clavere, P
    Malmstrom, A
    Jancar, B
    Newlands, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) : 987 - 996
  • [19] Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
    Teach, Stephen J.
    Gill, Michelle A.
    Togias, Alkis
    Sorkness, Christine A.
    Arbes, Samuel J., Jr.
    Calatroni, Agustin
    Wildfire, Jeremy J.
    Gergen, Peter J.
    Cohen, Robyn T.
    Pongracic, Jacqueline A.
    Kercsmar, Carolyn M.
    Hershey, Gurjit K. Khurana
    Gruchalla, Rebecca S.
    Liu, Andrew H.
    Zoratti, Edward M.
    Kattan, Meyer
    Grindle, Kristine A.
    Gern, James E.
    Busse, William W.
    Szefler, Stanley J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (06) : 1476 - 1485
  • [20] Vogel Wendy H, 2010, Clin J Oncol Nurs, V14, pE10, DOI 10.1188/10.CJON.E10-E21
123